AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 89,953 | 101,960 | 114,309 | 167,017 | 171,609 |
| Marketable Securities | 126,916 | 103,503 | 104,282 | 71,851 | 69,329 |
| Receivables | 468 | 372 | 310 | 419 | 351 |
| Other current assets | 1,067 | 4,920 | 723 | 761 | 1,697 |
| TOTAL | $221,702 | $212,862 | $222,616 | $243,729 | $247,203 |
| Non-Current Assets | |||||
| PPE Net | 5,597 | 5,506 | 5,670 | 5,412 | 4,710 |
| Investments And Advances | 397 | 396 | 399 | 369 | 356 |
| Intangibles | 55,160 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3,188 | 2,836 | 3,030 | 2,476 | 2,371 |
| TOTAL | $64,343 | $8,738 | $9,098 | $8,257 | $7,437 |
| Total Assets | $286,045 | $221,600 | $231,714 | $251,986 | $254,640 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,192 | 234 | 348 | 409 | 2,330 |
| Accrued Expenses | 18,311 | 14,499 | 11,648 | 10,760 | 11,823 |
| TOTAL | $21,911 | $15,496 | $13,005 | $12,298 | $14,952 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 785 | 134 | 382 | 641 | 326 |
| Other Non-Current Liabilities | 10,326 | 10,809 | 10,867 | 10,308 | 9,860 |
| TOTAL | $10,326 | $10,843 | $10,934 | $10,411 | $9,860 |
| Total Liabilities | $32,237 | $26,339 | $23,939 | $22,708 | $24,811 |
| Shareholders' Equity | |||||
| Common Shares | 1,963 | 1,731 | 1,689 | 1,701 | 1,640 |
| Retained earnings | -219,851 | -197,924 | -183,394 | -164,455 | -141,698 |
| Other shareholders' equity | -136 | -135 | -93 | -94 | -107 |
| TOTAL | $253,808 | $195,261 | $207,775 | $229,278 | $229,829 |
| Total Liabilities And Equity | $286,045 | $221,600 | $231,714 | $251,986 | $254,640 |